Publications

Skip to content

New and Noteworthy

Chronic lymphocytic leukemia

Topics

Chronic lymphocytic leukemia

Publications

Multiple myeloma

Diffuse large B-Cell lymphoma

Treatment patterns

Acute myeloid leukemia

Real-world evidence

Artificial intelligence

Health equity

Drug discovery

Content type

Publication summary

Video

Webinar

Press releases

Showing 8 of 0 results

Real-world clinical outcomes in patients with CLL previously treated with covalent BTKi and BCL2i regimens
Blood Neoplasia
Webinar: How breakthrough RWE is powering a new era of blood cancer research
Flatiron Health announces research to be presented at the 2025 American Society of Hematology’s Annual Meeting & Exposition
Mediators of racial and ethnic inequities in access to front-line therapies for chronic lymphocytic leukemia in the United States: A real-world evidence study
ASH Annual Meeting
A retrospective cohort study of real-world clinical outcomes in patients with CLL/SLL previously treated with covalent BTK inhibitor (cBTKi) and BCL2 inhibitor (BCL2i) regimens
ASCO Annual Meeting
The COVID-19 pandemic and in-person visit rate disruptions among patients with hematologic neoplasms in the US in 2020 to 2021
JAMA Network Open
Hepatitis B testing rates in patients with chronic lymphocytic leukemia before and during administration of anti-CD20 therapy
ASH Annual Meeting
Evidence of low incidence of myelodysplastic syndrome (MDS) in patients exposed to bendamustine treatment for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
ASCO Annual Meeting

Real answers to guide oncology’s highest-stakes decisions.

Resources
Publications
Company
Media
Careers
Contact Us

Real-World Evidence
Point of Care

Legal, Privacy, and Compliance
Cookie Settings
© FLATIRON HEALTH® 2026